Cameco Corp (CCJ) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, positive news catalysts, and favorable long-term analyst ratings outweigh the short-term price decline. The uranium market fundamentals remain tight, and Cameco is well-positioned to benefit from the accelerating momentum in nuclear energy and long-term contracts.
The technical indicators show mixed signals. The MACD is negative and expanding downward, indicating bearish momentum. The RSI is neutral at 38.839, and the stock is trading near its support level of 113.149. However, the bullish moving averages (SMA_5 > SMA_20 > SMA_200) suggest a longer-term uptrend. The stock is currently trading below the pivot point of 118.91, indicating a potential buying opportunity near support levels.

Cameco signed a $1.9 billion deal with India for uranium supply, enhancing long-term revenue visibility.
The U.S. and Japan's nuclear power collaboration reflects growing global demand for nuclear energy.
Analysts maintain strong ratings, with multiple price target increases, reflecting confidence in the company's prospects.
Short-term price decline of -4.99% in the regular market session and -2.99% in pre-market trading.
Neutral trading sentiment from hedge funds and insiders, indicating no significant buying activity.
In Q4 2025, Cameco reported strong financial performance with revenue up 1.50% YoY, net income up 46.94% YoY, EPS up 48.39% YoY, and gross margin up 7.68% YoY. These metrics indicate robust growth and profitability.
Analysts maintain a positive outlook on Cameco, with multiple 'Buy' and 'Outperform' ratings. Recent price target changes include increases from RBC (C$160), Stifel (C$180), and Goldman Sachs ($131), reflecting confidence in the company's long-term growth potential.